Skip to main content

Neuropsychiatric update: neuroimaging schizophrenia.

Psychopharmacol Bull. 2007;40(4):156-67. Neuropsychiatric update: neuroimaging schizophrenia. Kile SJ.
Psychopharmacol Bull. 2007;40(4):156-67. Neuropsychiatric update: neuroimaging schizophrenia. Kile SJ.
2007-07-20

Abstract

Abstract
Neuroimaging has revitalized the quest for the neurobiology of schizophrenia. The various neuroimaging modalities used in research are described including CT, MRI, PET, SPECT, fMRI, and DTI. Prominent and consistent neuroanatomical findings in the neuroimaging literature of schizophrenia are outlined. These findings, including enlargement of the lateral ventricles, undersized superior temporal gyrus, and prefrontal abnormalities, are supported with neuropathological studies of schizophrenia. Additionally, these findings are correlated with the clinical symptoms of schizophrenia. Neurochemical imaging studies of schizophrenia are reviewed and noted to support dopaminergic dysregulation consistent with the dopamine hypothesis. Finally, current and near-future clinical uses of neuroimaging are described.

PMID:18227785[PubMed - indexed for MEDLINE]

Shawn Kile
Shawn Kile
Principal investigator
View Profile

Research Topics

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?